Hyperhomocysteinaemia Promotes Doxorubicin-Induced Cardiotoxicity in Mice

Hyperhomocysteinaemia Promotes Doxorubicin-Induced Cardiotoxicity in Mice

Doxorubicin, a widely used chemotherapeutic drug in clinical oncology, causes a series of cardiac side effects referred to as doxorubicin-induced cardiotoxicity. Hyperhomocysteinaemia is an independent risk factor for multiple cardiovascular diseases. However, whether hyperhomocysteinaemia contribut...

Full description

Bibliographic Details
Main Authors: Rui Fan, Yao Wang, Jinjin Zhang, Xiangbo An, Shuang Liu, Jie Bai, Jiatian Li, Qiuyue Lin, Yunpeng Xie, Jiawei Liao, Yunlong Xia
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Pharmaceuticals
Subjects:
hyperhomocysteinaemia
homocysteine
methionine
doxorubicin
cardiotoxicity
folic acid
Online Access:https://www.mdpi.com/1424-8247/16/9/1212

Internet

https://www.mdpi.com/1424-8247/16/9/1212

Similar Items